This inventor holds 2 USPTO granted patents. Top assignee: Kikkoman Corporation. Active years: 1990-1993.
Company Filing History:
Years Active: 1990-1993
Title: Innovations of Shoichi Imai
Introduction
Shoichi Imai is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating heart failure. With a total of 2 patents, Imai's work has garnered attention in the scientific community.
Latest Patents
Imai's latest patents include innovations related to N.sup.6,N.sup.6-disubstituted-cyclic adenosine-3',5'-monophosphates. These patents describe a compound represented by a specific formula, wherein R represents a linear alkyl group with three or more carbon atoms or a branched alkyl group with four or more carbon atoms. The invention also details a cardiac composition that includes this compound as an effective component, along with a method for preparing it. This work is crucial for developing treatments for heart failure in mammals.
Career Highlights
Shoichi Imai is associated with Kikkoman Corporation, where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing the understanding and treatment of cardiovascular conditions.
Collaborations
Imai has collaborated with notable colleagues such as Shigehiro Kataoka and Nobuyuki Yamaji. Their combined efforts have contributed to the success of their research and innovations.
Conclusion
Shoichi Imai's contributions to the field of pharmaceuticals, particularly in the treatment of heart failure, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.